freya.intelligence

A global regulatory strategist can leverage the freya.regulations repository to quickly identify the latest vaccine-related updates from China by applying advanced filters- market (China), product type (Vaccines), and document date (last 3 months). The centralized database instantly surfaces a curated list of latest NMPA guidelines, updated lot release procedures, and revised safety surveillance timelines, each with summaries, source links, and download options, empowering faster local alignment and regulatory readiness.

To periodically monitor global changes impacting biologics, generics, and vaccines, a Regulatory Intelligence Lead can set up custom bi-monthly newsletters using freya.Alerts. By setting filters for regions (US, EU, Asia-Pacific) and document types (PV, Labelling, QMS), they receive summarized, SME-reviewed updates along with AI-generated insights, release dates, and source links, enabling faster alignment and proactive compliance across markets.

To identify quarterly regulatory shifts impacting pipeline planning, compliance risks, and resource allocation, a Regulatory Affairs Director can refer freya.Dashboards housing custom, interactive, real-time visualizations built from data across 1,800+ global health authorities. The dashboards reveal regulatory activity by market (US, EU, Asia, LATAM), product category spikes (vaccines, biosimilars, generics), topic breakdowns (PV, labeling, GMP) and timeline trends, empowering leadership to make faster, data-driven decisions on pipeline and compliance strategy.

To handle rising complexity in responding to health authority queries, a global regulatory submission team turns to freya.RTQ. The platform centralizes historic and ongoing RTQs into a structured, searchable repository powered by AI for rapid retrieval and first-draft response creation. They can simply ask “I’ve been asked to provide a risk assessment for nitrosamines during a GMP inspection for Losartan. Can you help me draft a response?” and the system pulls context from historic responses, applies AI-assisted drafting, and suggests a consistent, compliant answer, reducing turnaround time, improving quality, and revealing recurring agency patterns, streamlining every step from intake to submission.

Digital health teams can use freya.Regulations to filter recent FDA updates on Software as a Medical Device by market, product type, and date range. In seconds, they retrieve targeted documents on cybersecurity, clinical evaluation, and device software functions. With direct access to the latest guidance, teams align submission plans, minimize regulatory queries, and accelerate time to market.

Regulatory teams managing diagnostics, surgical tools, and wearables can configure freya.Alerts to receive tailored newsletters on evolving requirements across US, EU, China, and Japan. By filtering for product class and topics like UDI, labeling, and clinical evaluation, teams get weekly updates with summaries and source links enabling faster action, reduced compliance risk, and better coordination across global markets.

Medical device teams can refer the Standards Dashboard to track ISO, IEC, ASTM, and national standards across markets in one centralized view. With filters by standard number, topic, and issuing body, plus AI-generated summaries and direct purchase links, teams stay updated on changes in areas like sterilization, software, and risk management, reducing manual tracking and ensuring timely updates to design a QMS documentation.

Medical device teams can leverage freya.RTQ to log, search, and respond to Notified Body and Health Authority queries with consistency and speed. AI-powered search retrieves past responses, while automated workflows route tasks and approvals. Dashboards track recurring issues reducing turnaround time by 40%, standardizing communication, and helping pre-empt common NB concerns in future MDR submissions.

OTC Product teams use interactive claims dashboards to validate and compare health claims like “boosts immunity” or “relieves headaches” across multiple markets. It delivers market-wise claim classification (therapeutic, functional, structure-function), permission status (allowed, restricted, conditional), and labelling instructions down to font, placement, and warning text. Teams can also receive RDA-based compliance checks and source links, helping accelerate launches, reduce regulatory risk, and ensure globally consistent, compliant messaging.

Consumer health teams can receive timely regulatory alerts on label changes, dosage limits, and claim updates tailored by product type, market, and category. Whether it’s a revised allergen warning in the EU or new font size rules in LATAM, get curated updates straight to your inbox with source links and effective dates with freya.Alerts.

Cosmetics teams can filter EU-specific updates on ingredients, allergens, and documentation using freya.Regulations. By narrowing by region, product type, and focus area, they instantly access SCCS opinions, Annex III allergen rules, and CPSR guidance with expert summaries, source links, and grouped documents. This enables faster reformulation decisions, early packaging updates, and full compliance in under 30 minutes.

When a GRASE update affects multiple SKUs, consumer health teams can use the Impact Assessment module to instantly identify impacted products, outdated label language, and region-specific actions. With trigger analysis, stakeholder assignments, and real-time dashboards, teams align R&D, labelling, and compliance, enabling pre-emptive updates, cross-functional coordination, and leadership-ready impact summaries within 24 hours.